Find the Perfect Plan for Your Investment Journey
D
Latest price
52 Week Range
CA$0.48 - CA$1.74
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$48.71M |
EV | CA$49.86M |
Shares Outstanding | 56.19M |
Beta | 1.40 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E undefinedE | - |
P/Revenue undefinedE | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin undefinedE | - |
Net Profit Margin undefinedE | - |
ROE undefinedE | - |
ROCE | - |
DPS undefinedE | - |
Payout Ratio undefinedE | - |
Div. Yield undefinedE | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
D
Defence Therapeutics Inc.
DTC
Sector
Healthcare
Industry
Biotechnology
CEO
Plouffe, Sebastien
Employees
Website
defencetherapeutics.comIPO Date
2021-05-10
Headquarters
1680 – 200 Burrard Street, Vancouver, British Columbia, V6C 3L6, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved